Amantadine in methamphetamine-dependent patients
Phase 2
Recruiting
- Conditions
- Craving and relapse reduction in methamphetamine-dependent patients.
- Registration Number
- IRCT20090801002266N16
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
18-60 years old patients
The participants who meet the criteria of methamphetamine use disorder based on DSM-V
Only depend on methamphetamine
Patients' satisfaction for participation in the study
Exclusion Criteria
Psychiatric drugs administration
The concurrent major psychiatric disorders such as mood and thinking disorders
Major and chronic physical disorders
Pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amantadine add-on therapy effects on craving and relapse reduction among patients with methamphetamine dependence. Timepoint: Methamphetamine urine test will be done weekly during the intervention and monthly in follow-up period. Method of measurement: CCQ-Brief Questionnaire.
- Secondary Outcome Measures
Name Time Method Anxiety. Timepoint: Before and 2 months after the Intervention. Method of measurement: Hospital Anxiety - Depressive Scale.;Depression. Timepoint: Before and 2 months after the Intervention. Method of measurement: Hospital Anxiety - Depressive Scale.